It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...

ATLANTA (AP) — CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the ...

Democratic governors are creating coalitions to institute vaccine guidance as public health experts lose faith in the CDC.

Lesotho reached a milestone late last year — UNAIDS’s 95-95-95 goal, with 95% of people living with HIV aware of their status ...

The Trump administration has reinstated hundreds of CDC staffers who were mistakenly laid off last week due to what an HHS ...

Public health experts are speaking out against furloughs at the Atlanta-based CDC they say have left hundreds of workers ...

NEW YORK (Reuters) -Americans headed to pharmacies for COVID-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that abandoned broad support for the shots, contributing to ...